Cardio Diagnostics Holdings, Inc.
CDIONASDAQHealthcare● Active
$1.90
$-0.09(-4.52%)
Market Cap$3934188
P/E Ratio—
52W High$7.91
52W Low$0.97
Cardio Diagnostics Holdings, Inc.（CDIO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CDIO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($6.50M) | ($8.38M) | ($8.38M) | ($4.66M) | ($0.62M) |
| Depreciation & Amort. | $0.16M | $0.28M | $0.11M | $0.02M | $0.02M |
| Stock-Based Comp. | $0.11M | $2.59M | $1.28M | $0.00M | $0.06M |
| Change in Working Capital | $0.26M | $0.52M | $0.21M | ($0.56M) | ($0.04M) |
| Net Cash from Operations | ($5.73M) | ($4.99M) | ($5.67M) | ($5.09M) | ($0.59M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.19M) | ($0.40M) | ($0.79M) | $0.00M | ($0.11M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.42M) | ($0.40M) | ($0.79M) | ($0.37M) | ($0.36M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.37M) | $0.00M | $4.50M | ($0.19M) | $0.00M |
| Net Cash from Financing | $3.43M | $11.94M | $3.63M | $9.06M | $1.23M |
| Free Cash Flow | |||||
| Free Cash Flow | ($5.91M) | ($5.40M) | ($6.47M) | ($5.09M) | ($0.70M) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Cardio Diagnostics Holdings, Inc.
关于Cardio Diagnostics Holdings, Inc.（CDIO）现金流量表
Cardio Diagnostics Holdings, Inc. 2025财年经营活动现金流($0.01B)，自由现金流($0.01B)（FCF利润率-39893.09%），资本支出($0.00B)。
常见问题
CDIO · 4 问Cardio Diagnostics Holdings, Inc. 2025财年自由现金流($0.01B)，同比down9.6%。
CDIO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10